![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Alvarado Yesid Kantarjian Hagop M. Luthra Rajyalakshmi Ravandi Farhad Borthakur Gautam Garcia-Manero Guillermo Konopleva Marina Estrov Zeev Andreeff Michael Cortes Jorge E.
Publisher: Blackwell Publishing
E-ISSN: 1097-0142|120|14|2142-2149
ISSN: 0008-543X
Source: Cancer, Vol.120, Iss.14, 2014-07, pp. : 2142-2149
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Current Pharmaceutical Design, Vol. 10, Iss. 16, 2004-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel FLT3 tyrosine kinase inhibitors
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Small Molecule FLT3 Tyrosine Kinase Inhibitors
Current Pharmaceutical Design, Vol. 10, Iss. 11, 2004-04 ,pp. :